Page 5 - Time Dynamix News Today

Share this article Share this article EXTON, Pa., Feb. 10, 2021 /PRNewswire/ -- Despite the potential for setbacks brought forth by the COVID-19 pandemic, Amgen recently reported strong year-over-year growth for their newly acquired psoriasis (PSO) and psoriatic arthritis (PsA) agent, Otezla. 1 In late 2019, the brand was sold to Amgen in order to clear the path for Bristol-Myers Squibbs acquisition of Celgene, considering future regulatory conflicts with BMS pipeline psoriasis drug, deucravac...

Share this article Share this article EXTON, Pa., Jan. 20, 2021 /PRNewswire/ -- Two 2020 European Medical Agency (EMA) approvals, Takedas Entyvio SC and Celltrion Healthcares infliximab biosimilar, Remsima SC, have captured notable shares among EU5 IBD patients, according to Spherixs recent report, RealTime Dynamix™: Inflammatory Bowel Disease (EU). The report sampled 246 EU5 gastroenterologists in November and December of 2020. While both new, subcutaneous market entrants have mostly gained...